This NDC is on FDA's drug shortage list (posted Apr 7, 2020)
Reported reason: Requirements related to complying with good manufacturing practices
Product Information
FUROSEMIDE 20 MG/2 ML VIAL is a generic product labeled by Accord Healthcare Inc., priced at $0.4154 per ML under NDC 16729050008. Its NADAC has been published 110 times since Apr 17, 2024.
FDA first approved this application on Dec 15, 1986. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Accord Healthcare Inc.NDC
16729050008
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
5/20/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA070017FDA Approved
12/15/1986
TE Code
AP
On Market Since
5/5/2021
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 20 MG/2 ML VIAL has been published 110 times since Apr 17, 2024, and over the history we have for it it has declined 33.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4154 per ML |
|---|---|
| All-time high | $0.6277 (May 15, 2024) |
| All-time low | $0.3473 (Dec 17, 2025) |
| 52-week high | $0.4154 |
| 52-week low | $0.3473 |
| Median price | $0.4073 |
| Average price | $0.4372 |
| Largest weekly change | -22.5% (Dec 18, 2024) |
| Weeks tracked | 110 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
+12.3%
1Y
+10.9%
3Y
N/A
5Y
N/A
All
-33.8%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FUROSEMIDE 20 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 20 MG/2 ML VIAL, manufactured by Accord Healthcare Inc., is $0.4154 per ML (NDC 16729050008), effective May 20, 2026.
How has the price of FUROSEMIDE 20 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has declined 33.8%. It has been tracked across 110 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 20 MG/2 ML VIAL?
Since Apr 17, 2024, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has ranged from a low of $0.3473 (Dec 17, 2025) to a high of $0.6277 (May 15, 2024), with a median of $0.4073 per ML.
Are there cheaper alternatives to FUROSEMIDE 20 MG/2 ML VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2658 per ML — about 36% below FUROSEMIDE 20 MG/2 ML VIAL.
Who manufactures FUROSEMIDE 20 MG/2 ML VIAL?
FUROSEMIDE 20 MG/2 ML VIAL (NDC 16729050008) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Is FUROSEMIDE 20 MG/2 ML VIAL in shortage?
Yes — NDC 16729050008 is currently listed in FDA's drug shortage database (posted Apr 7, 2020). Reported reason: Requirements related to complying with good manufacturing practices.